期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性冠脉综合症患者血清胆红素尿酸及纤维蛋白原变化的临床意义 被引量：3

Clinic study of serum bilirubin,uric acid and fibrinogen in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨急性冠脉综合症(ACS)患者血清胆红素(Bil)、尿酸(UA)及纤维蛋白原(Fib)水平的变化及临床意义。方法检测109例ACS(ACS组)患者及55例(对照组)健康体检者的外周血清胆红素、尿酸及纤维蛋白原水平。ACS组分为不稳定性心绞痛(UAP组)和急性心肌梗塞(AMI组)两个亚组。结果与对照组相比,ACS组外周血清尿酸、纤维蛋白原水平明显升高(P<0.05),血清胆红素水平明显降低(P<0.05)。但ACS亚组之间,血清胆红素、尿酸及纤维蛋白原水平则没有明显差异(P>0.05)。结论联合检测外周血清胆红素、尿酸和纤维蛋白原浓度在急性冠脉综合症的诊断、治疗和预后中具有重要的临床价值。 Objective To study the clinic value of serum bilirubin （Bil）, uric acid （UA） and fibrinogen （Fib） in acute coronary syndrome patients. Methods Fasting vein blood was gathered to examine the serum Bil, UA and Fib level in 109 patients of acute coronary syndrome （ACS） and 55 healthy compared participants. The ACS group was divided into two subgroups unstable angina （UAP） and acute myocardial infarction （AMI）. Results The level of UA and Fib in ACS group were significantly higher than that of control group （P〈0. 05） and the level of Bil in ACS group was significantly decreased compared to control group（P〈0. 05）. However, there was no significant difference of serum Bil, UA and Fib between ACS subgroups. Conclusion There is a vital value of examining serum Bil, UA and Fib concentration in diagnose, treatment and prognosis of Acute coronary Syndrome.
作者 易全会 程亚玲
机构地区 广安市人民医院心内科
出处 《西部医学》 2013年第1期96-97,99,共3页 Medical Journal of West China
关键词 急性冠脉综合症 血清 胆红素 尿酸 纤维蛋白原 Acute coronary Syndrome Serum Bilirubin Uric acid Fibrinogen
分类号 R543.3 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1Auer J,Berent R,Iassnig E. C-reactive protein and coronary artery[J].Japanese Heart Journal,2002,(06):607.
  • 2Libby P,Theroux P. Pathophysiology of coronary artery disease[J].Circulation,2005,(25):3481-3488.
  • 3杨彬,陈凤华.动脉粥样硬化患者血清胆红素浓度的变化[J].医学理论与实践,2008,21(2):135-136. 被引量：14
  • 4刘文波,殷少华,孙晓健,刘少荣,仲琳.冠心病患者血清尿酸和胆红素水平的变化[J].中华心血管病杂志,2003,31(6):439-439. 被引量：60
  • 5Bickel C,Rupprecht HJ. Serum uric acid as an independent predictor of mortality in patients with angiographically provent coronary artery disease[J].American Journal of Cardiology,2002.12-17.
  • 6James JS,Halit S,Geoffrey HT. Association of fibrinogen with cardiovascular risk factor and cardiovascular disease in the Framingham off spring population[J].Circulation,2000.1634-1638.
  • 7Meiyan L,Dayi H. The research and development of fibrinogen and coronary heart disease[J].Chinese Journal of Medical Guide,2005.335-338.
  • 8Schewertner HA,Fisher JE. Comparision of various lipid lipoprotein,and bilirubin conbinations as risk factors for predicting coronary artery disease[J].Atheroclerosis,2000,(02):381-387.
  • 9Greabu M,Olinescu R,Kummerow FA. The levels of bilirubin may be related to an inflammatory condition in patients with coronary heart disease[J].Acta Poloniae Pharmaceutica,2001,(03):2252-2231.
  • 10Gullu H,Erdogan D,Tok D. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2005,(11):2289-2294.

二级参考文献14

  • 1彭定凤,余意君,成忠,胡立群,顾晔.血清胆红素与冠心病的关系[J].临床心血管病杂志,2004,20(12):728-729. 被引量：15
  • 2徐文苑,郑泽琪.血清胆红素与脑梗死及其危险因素的关系研究[J].临床荟萃,2006,21(19):1396-1397. 被引量：18
  • 3[1]Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem, 1994; 40:18
  • 4[2]Breimer LH, Wannamethee G, Ebrahim S, et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem, 1995; 41(10):1504
  • 5[3]Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem, 1994; 269:16712
  • 6[4]Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibitis the oxidation of human low density lipoprotein better than Trolox. Life Sci, 1994; 54(25):477
  • 7[5]Hopkins PN, Wu LL, Hunt SC, et al.Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol, 1996; 16(2):250
  • 8[6]Nakagami T, Toyomura K, Kinoshita T, et al. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated birlirubin. Biochim Biophys Acta, 1993; 1158:189
  • 9Brand FN, Megee DL, Kannel, WB, et al. Hyperuricenmia as a risk of coronary heart disease: the framingham study. Am J Epidemiol,1985,121:11-18.
  • 10Freedam DS, Williamson DF, Gunter EW, et al. Relation of serum uric acid to mortality and ischemic heart disease. The nhanesi epidemiologic follow up study. Am J Epidemiol, 1995,141:637-644.

共引文献75

同被引文献32

  • 1雷红华,王云华,乔姝.肌钙蛋白T(CTnT)在急性冠状动脉综合征的应用[J].l中外健康文摘,2012,9(44):91-92.
  • 2刘彦文.心肌酶谱和肌钙蛋白T对于急性心肌梗塞诊断的意义[J].中外健康文摘,2012,9(20):243-244.
  • 3Wang Y, Liang WC, Pan WL, etal. Silibinin, a novel chemo- kine receptor type 4 antagonist, inhibits chemokine ligand 12-in- duced migration in breast cancer cells [J]. Phytomedicine, 2014, 21(11):1310-1317.
  • 4Wang YX, Cai H, Jiang G, et al. Silibinin Inhibits Prolifera- tion, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition [J]. Asian Pac J Cancer Prev. 2014, 15(16), 6791-6798.
  • 5Chen YH, Chen CL, Liang CM, et al. Silibinin inhibits ICAM- 1 expression via regulation of N-linked and O-linked glycosyla- tion in ARPE-19 cells [J]. Biomed Res Int. 2014, (7):01395.
  • 6Yousefi M, Ghaffari SH, Zekri A, et al. Silibinin induces apop- tosis and inhibits proliferation of estrogen receptor (ER)-nega- tive breast carcinoma ceils through suppression of nuclear factor kappa B activation [J]. Arch Iran Med. 2014, 17(5) :366-371.
  • 7Kim BR, Seo HS, Ku JM, et al. Silibinin inhibits the produc- tion of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells [J]. Inflamm Res. 2013, 62(11): 941-950.
  • 8Liu W, Otkur W, Zhang Y, etal. Silibinin protects murine fibroblast L929 ceils from UVB-induced apoptosis through the simultaneous inhibition of ATM-pS3 pathway and autophagy [J]. FEBS J. 2013, 280(18) : 4572-4584.
  • 9Choi YH, Jin GY, Guo HS, et at. Silibinin attenuates allergic airway inflammation in mice [J]. Biochem Biophys Res Com- mun. 2012, 427(3): 450-455.
  • 10Wang C, Wang Z, Zhang X, et al. Protection by silibinin a- gainst experimental ischemic stroke: up-regulated pAkt, pro-TOR, HIF-I~ and Be[-2, down-regulated Bax, NF-KB expres- sion[J]. Neurosei Lett. 2012, 529(1): 45-50.

引证文献3

二级引证文献3

西部医学
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部